|
|
||||||||
Animal: DNA Viruses |
Max von Pettenkofer-Institut, Lehrstuhl Virologie, Ludwig-Maximilians-Universität München, Pettenkoferstrasse 9a, 80336 München, Germany1
Author for correspondence: Hartmut Hengel. Present address: Robert Koch-Institut, Division of Viral Infections, Nordufer 20, 13353 Berlin, Germany. Fax +49 1888 754 2328. e-mail hengelh{at}rki.de
Liver and intestinal epithelial cells are a major target of infection by cytomegaloviruses (CMV), causing severe disease in affected organs of immunocompromised patients. CMV downregulates major histocompatibility complex class I (MHC-I) molecule expression in fibroblasts in order to avoid lysis by CD8+ cytotoxic T lymphocytes. However, MHC-I expression in human cytomegalovirus (HCMV)-infected hepatic tissue was reported to be increased. As it is unclear at present whether HCMV affects MHC-I expression in epithelial cells, new cell culture models for HCMV infection of differentiated hepatobiliary cell lines were established. HCMV immediate early gene expression was achieved in 60 to 95% of cells. Progression of the HCMV replication cycle differed from prototypic infection of fibroblasts, since structural early and late proteins were produced at low levels and HCMV progeny yielded much lower titres in hepatobiliary cells. In contrast, HCMV glycoproteins, gpUS2, gpUS3, gpUS6 and gpUS11, that downregulate MHC-I expression were synthesized with temporal kinetics and in a similar quantity to that seen in fibroblasts. As a result, HCMV infection led to a drastic and selective downregulation of MHC-I expression in epithelial cells and was uniformly observed irrespective of the hepatic or biliary origin of the cells. The new models document for the first time a stealth function of HCMV in epithelial cells and indicate that the downregulation of MHC-I expression by HCMV can occur in the virtual absence of virus replication.
This article has been cited by other articles:
![]() |
S. Sengupta, J. A. den Boon, I-H. Chen, M. A. Newton, D. B. Dahl, M. Chen, Y.-J. Cheng, W. H. Westra, C.-J. Chen, A. Hildesheim, et al. Genome-Wide Expression Profiling Reveals EBV-Associated Inhibition of MHC Class I Expression in Nasopharyngeal Carcinoma Cancer Res., August 15, 2006; 66(16): 7999 - 8006. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Halenius, F. Momburg, H. Reinhard, D. Bauer, M. Lobigs, and H. Hengel Physical and Functional Interactions of the Cytomegalovirus US6 Glycoprotein with the Transporter Associated with Antigen Processing J. Biol. Chem., March 3, 2006; 281(9): 5383 - 5390. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Khan, A. Zimmermann, M. Basler, M. Groettrup, and H. Hengel A Cytomegalovirus Inhibitor of Gamma Interferon Signaling Controls Immunoproteasome Induction J. Virol., February 15, 2004; 78(4): 1831 - 1842. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |